《中国老年血脂异常管理专家共识》
[Chinese expert consensus on management of dyslipidemia in the elderly].
作者信息
Liu M L, Zhang Z F, Fu P, Ye Y F, Guo F, Wang Q, He J J, Li X W, Yan Y H, Liao X F, Zhou X P, Tuo Z H, Wang Zhaohui
机构信息
Department of Geriatrics, Peking University First Hospital, Beijing 100034, China.
Department of Cardiology, Second Medical Center, PLA General Hospital, Beijing 100853, China.
出版信息
Zhonghua Nei Ke Za Zhi. 2022 Oct 1;61(10):1095-1118. doi: 10.3760/cma.j.cn112138-20220407-11251.
Dyslipidemia is an important risk factor of atherosclerotic cardiovascular disease (ASCVD). Statins delay the occurrence and development of ASCVD, and reduce the risk of cardiovascular events and death. Due to safety concerns, there exist insufficient use of lipid-lowering agents and a high withdrawal rate of the agents in the elderly. To promote the prevention and treatment of ASCVD, this expert consensus is issued and focuses on the management of dyslipidemia of Chinese elderly basing on the clinical evidence of the use of lipid-lowering drugs by the elderly, and the lipid management guidelines and expert consensus recommendations at home and abroad.
血脂异常是动脉粥样硬化性心血管疾病（ASCVD）的重要危险因素。他汀类药物可延缓ASCVD的发生和发展，并降低心血管事件和死亡风险。由于安全顾虑，老年人降脂药物使用不足且药物停用率高。为促进ASCVD的防治，基于老年人使用降脂药物的临床证据以及国内外血脂管理指南和专家共识建议，发布本专家共识，重点关注中国老年人血脂异常的管理。
Zotero 插件